Curative Net Working Capital from 2010 to 2024
| CUBT Stock | USD 0.01 0.0001 1.16% |
Net Working Capital | First Reported 2010-12-31 | Previous Quarter -4 M | Current Value -3.8 M | Quarterly Volatility 1.6 M |
Check Curative Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Curative Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Depreciation And Amortization of 94.5 K or Selling General Administrative of 1.7 M, as well as many indicators such as Price To Sales Ratio of 4.04, Dividend Yield of 0.0 or Days Sales Outstanding of 267. Curative financial statements analysis is a perfect complement when working with Curative Biotechnology Valuation or Volatility modules.
Curative | Net Working Capital |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.